Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers
Home › MA › NORWOOD › STEWARD NORWOOD HOSPITAL, INC.

STEWARD NORWOOD HOSPITAL, INC.

NPI: 1952613416 · NORWOOD, MA 02062 · General Acute Care Hospital · NPI assigned 07/12/2010

Billing Flags · Automated signals — not evidence of fraud
Entity Proliferation

Authorized official RENNA, JAMES controls 11+ related entities in our dataset. Read more

$8.47M
Total Medicaid Paid
198,560
Total Claims
163,484
Beneficiaries
182
Codes Billed
2018-01
First Month
2024-09
Last Month

Provider Details

Authorized OfficialRENNA, JAMES (CHIEF FINANCIAL OFFICER)
Parent OrganizationSTEWARD HEALTH CARE SYSTEM LLC
NPI Enumeration Date07/12/2010

Related Entities

Other providers sharing the same authorized official: RENNA, JAMES

ProviderCityStateTotal Paid
STEWARD HOLY FAMILY HOSPITAL, INC. METHUEN MA $70.80M
STEWARD GOOD SAMARITAN MEDICAL CENTER, INC. BROCKTON MA $64.10M
STEWARD CARNEY HOSPITAL, INC. DORCHESTER CENTER MA $56.76M
STEWARD ST. ELIZABETH'S MEDICAL CENTER OF BOSTON, INC. BOSTON MA $32.53M
STEWARD ST. ELIZABETH'S MEDICAL CENTER OF BOSTON, INC. BOSTON MA $1.90M
STEWARD HOLY FAMILY HOSPITAL, INC. METHUEN MA $1.06M
NEW ENGLAND SINAI HOSPITAL, A STEWARD FAMILY HOSPITAL, INC. STOUGHTON MA $136K
STEWARD CARNEY HOSPITAL, INC. DORCHESTER CENTER MA $52K
STEWARD GOOD SAMARITAN MEDICAL CENTER, INC. BROCKTON MA $29K
MORTON HOSPITAL, A STEWARD FAMILY HOSPITAL, INC. TAUNTON MA $11K
STEWARD ST. ANNE'S HOSPITAL CORPORATION FALL RIVER MA $3K

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 86,068 $3.70M
2019 76,181 $3.17M
2020 26,454 $1.09M
2021 3,478 $149K
2022 3,045 $160K
2023 1,800 $113K
2024 1,534 $88K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99283 Emergency department visit for the evaluation and management, moderate severity 10,397 9,473 $1.56M
99284 Emergency department visit for the evaluation and management, high severity 7,594 6,919 $1.07M
99285 Emergency department visit for the evaluation and management, high severity with immediate threat to life 6,409 5,696 $947K
96361 Intravenous infusion, hydration; each additional hour 3,565 2,851 $877K
99282 Emergency department visit for the evaluation and management, low to moderate severity 2,327 2,177 $358K
74177 Computed tomography, abdomen and pelvis; with contrast material 1,496 1,380 $345K
70450 Computed tomography, head or brain; without contrast material 1,820 1,672 $287K
77067 Screening mammography, bilateral, including computer-aided detection 4,594 4,539 $255K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple 474 461 $241K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 1,370 1,004 $165K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 2,590 818 $151K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 3,919 3,412 $134K
77063 Screening digital breast tomosynthesis, bilateral 1,705 1,688 $120K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction 940 842 $104K
71046 Radiologic examination, chest; 2 views 5,594 5,205 $100K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour 806 733 $99K
59025 Fetal non-stress test 465 235 $95K
74176 Computed tomography, abdomen and pelvis; without contrast material 293 270 $85K
76705 Ultrasound, abdominal, real time with image documentation; limited 573 552 $78K
45380 Colonoscopy, flexible; with biopsy, single or multiple 258 252 $74K
G0378 Hospital observation service, per hour 3,089 1,134 $70K
95810 Polysomnography; sleep staging with 4 or more additional parameters 72 68 $63K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 13,780 10,865 $62K
87631 645 600 $57K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 1,141 1,045 $52K
70551 Magnetic resonance imaging, brain; without contrast material 103 99 $47K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 2,157 1,877 $44K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 295 179 $41K
76642 441 381 $40K
76816 Ultrasound, pregnant uterus, real time with image documentation, follow-up 210 171 $37K
ATP14 4,225 3,258 $35K
93971 102 98 $33K
88305 Level IV - Surgical pathology, gross and microscopic examination 1,726 1,645 $33K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance 125 75 $30K
84600 2,630 2,298 $28K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 4,452 4,033 $28K
80053 Comprehensive metabolic panel 10,078 8,736 $28K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 1,769 1,438 $23K
84484 4,385 3,024 $22K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types 856 833 $21K
71250 237 223 $19K
76536 181 178 $18K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 338 304 $18K
77080 316 308 $18K
71275 Computed tomographic angiography, chest, with contrast material 69 62 $16K
73630 528 486 $15K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour 69 54 $15K
72125 Computed tomography, cervical spine; without contrast material 414 388 $15K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 5,943 5,120 $15K
99219 34 16 $14K
93010 Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only 2,168 1,982 $13K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 1,302 1,248 $13K
72100 352 337 $13K
96375 Therapeutic injection; each additional sequential IV push 3,218 2,611 $13K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 1,630 803 $12K
81025 2,427 2,237 $12K
88142 701 691 $12K
83690 2,111 1,878 $10K
77065 Tomosynthesis, mammo 122 115 $9K
87086 Culture, bacterial; quantitative colony count, urine 1,839 1,674 $9K
U0004 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r 140 133 $9K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity 63 51 $8K
ATP08 1,311 848 $8K
71271 177 177 $8K
83605 1,385 1,065 $8K
76830 Ultrasound, transvaginal 63 57 $8K
73610 341 323 $8K
81001 3,637 3,305 $7K
84702 576 499 $7K
76770 41 38 $7K
80048 Basic metabolic panel (calcium, ionized) 4,104 3,108 $6K
85379 906 838 $6K
87081 1,135 1,082 $6K
76700 Ultrasound, abdominal, real time with image documentation; complete 44 40 $6K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete 159 141 $5K
72148 Magnetic resonance imaging, lumbar spine; without contrast material 46 44 $5K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal 44 37 $5K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 374 351 $5K
83735 1,362 1,015 $5K
73030 297 272 $5K
86850 668 587 $5K
J1642 Injection, heparin sodium, (heparin lock flush), per 10 units 745 452 $4K
G0399 Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation 29 27 $4K
99291 Critical care, evaluation and management of the critically ill patient, first 30-74 minutes 33 26 $4K
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 28 28 $4K
74018 183 173 $4K
87040 745 431 $4K
73130 179 162 $4K
88313 402 381 $4K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 143 130 $3K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 143 130 $3K
83880 253 216 $3K
G0463 Hospital outpatient clinic visit for assessment and management of a patient 149 116 $3K
90715 115 109 $3K
ATP15 380 278 $3K
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 654 606 $3K
J1885 Injection, ketorolac tromethamine, per 15 mg 3,534 2,677 $3K
81003 2,012 1,838 $3K
36415 Collection of venous blood by venipuncture 7,947 5,737 $2K
G0123 Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision 820 799 $2K
97161 44 40 $2K
J2405 Injection, ondansetron hydrochloride, per 1 mg 3,648 2,790 $2K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete 14 13 $2K
85027 581 469 $2K
87186 432 377 $2K
12001 12 12 $2K
86900 714 626 $2K
J1644 Injection, heparin sodium, per 1000 units 989 388 $2K
84703 285 261 $2K
73110 73 64 $2K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) 169 61 $2K
86901 715 626 $1K
93017 14 12 $1K
G0297 Low dose ct scan (ldct) for lung cancer screening 26 26 $1K
85610 922 678 $1K
71045 Radiologic examination, chest; single view 842 738 $1K
88342 439 417 $1K
80050 General health panel 94 80 $1K
87077 397 344 $1K
84443 Thyroid stimulating hormone (TSH) 224 200 $1K
82947 1,751 864 $1K
76801 14 14 $1K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 1,975 1,857 $1K
87070 234 183 $1K
73502 56 54 $982.80
73564 30 25 $933.22
J1170 Injection, hydromorphone, up to 4 mg 915 482 $895.28
J2270 Injection, morphine sulfate, up to 10 mg 791 459 $812.56
83036 Hemoglobin; glycosylated (A1C) 178 144 $698.33
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 27 26 $633.42
86140 174 149 $570.43
77066 Tomosynthesis, mammo 13 13 $567.52
87147 132 117 $537.86
80177 54 50 $530.77
87205 187 152 $475.86
85244 61 45 $475.00
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 12 12 $463.76
J2704 Injection, propofol, 10 mg 2,942 2,016 $454.41
85280 61 45 $450.22
J3490 Unclassified drugs 123 95 $411.64
88304 160 149 $392.82
96376 142 128 $389.61
J2060 Injection, lorazepam, 2 mg 753 553 $333.07
80076 603 521 $322.50
J7512 Prednisone, immediate release or delayed release, oral, 1 mg 198 146 $294.46
85652 178 153 $277.86
73140 16 12 $250.48
J0690 Injection, cefazolin sodium, 500 mg 533 403 $227.01
J1100 Injection, dexamethasone sodium phosphate, 1 mg 932 712 $223.93
85651 105 97 $217.42
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc 226 210 $209.62
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine 155 141 $194.52
J2250 Injection, midazolam hydrochloride, per 1 mg 866 741 $189.95
85007 130 105 $184.08
J3010 Injection, fentanyl citrate, 0.1 mg 1,324 853 $182.57
73562 38 36 $150.79
J0696 Injection, ceftriaxone sodium, per 250 mg 95 66 $124.32
85730 28 25 $86.80
81015 31 26 $43.96
ATP03 16 12 $34.25
J1200 Injection, diphenhydramine hcl, up to 50 mg 368 291 $31.99
A9585 Injection, gadobutrol, 0.1 ml 152 144 $31.75
82553 17 17 $17.58
82565 46 38 $14.65
C9113 Injection, pantoprazole sodium, per vial 49 26 $9.10
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg 1,196 1,045 $6.86
82550 17 16 $4.70
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg 14 13 $2.36
J2765 Injection, metoclopramide hcl, up to 10 mg 65 58 $0.60
J7644 Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram 46 38 $0.22
J0780 Injection, prochlorperazine, up to 10 mg 14 12 $0.00
J3475 Injection, magnesium sulfate, per 500 mg 40 25 $0.00
80061 Lipid panel 147 132 $0.00
J2710 Injection, neostigmine methylsulfate, up to 0.5 mg 15 15 $0.00
84520 29 25 $0.00
G8979 Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting 28 24 $0.00
J7050 Infusion, normal saline solution, 250 cc 295 189 $0.00
J0330 Injection, succinylcholine chloride, up to 20 mg 161 97 $0.00
80329 13 12 $0.00
J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg 91 50 $0.00
71260 Computed tomography, thorax, diagnostic; with contrast material 13 12 $0.00
J2370 Injection, phenylephrine hcl, up to 1 ml 15 14 $0.00